Randall L. Vanderveen

Biography

Randall “Pete” Vanderveen, Ph.D., was elected to the board of directors of Mylan in 2002. He is a member of the Mylan Compliance Committee and Science and Technology Committee. Dr. Vanderveen is currently Professor of Pharmaceutical Policy and Economics, Senior Adviser to the Leonard D. Schaeffer Center of Heath Policy and Economics, Director of the Margaret and John Biles Center for Leadership, and Senior Adviser to the Dean for Advancement at the School of Pharmacy, University of Southern California in Los Angeles, California. Vanderveen previously served as Dean, Professor and John Stauffer Decanal Chair of the University of Southern California School of Pharmacy from 2005-2015 where he was named “Outstanding Pharmacy Dean in the Nation” in 2013 by the American Pharmacist Association. During Dr. Vanderveen’s tenure as Dean, the School of Pharmacy rose from a U.S. News and World Report ranking of 19th to the 9th in the country among the over 160 Pharmacy Schools in the nation. From 1998 until 2005, he was Dean and Professor of Pharmacy of the School of Pharmacy and the Graduate School of Pharmaceutical Sciences at Duquesne University in Pittsburgh. Previously, he served in a variety of academic positions at Oregon State University/Oregon Health Sciences University and Ferris State University. Vanderveen has practiced pharmacy in independent community pharmacies, chain drug stores, nursing home settings and hospital pharmacies. He is board-certified as a psychiatric pharmacist by the Board of Pharmaceutical Specialties. Vanderveen has served as consultant and advisor to McKesson, Rite Aid, Eckerd, Walgreens, Bristol-Myers Squibb, Upjohn, Merck and Pfizer. Vanderveen has also served as a consultant to the Oregon Medical Assistance Program, the Michigan Department of Mental Health, Providence Medical Center, the Veterans Administration Hospital and the Oregon Health Sciences Hospital in Portland, Ore. Vanderveen was honored as a "Fellow" in both the American Pharmacists Association and the American Society of Health-Systems Pharmacists (ASHP). He is a member and former board of directors member of the American Association of Colleges of Pharmacy and a member of the board of directors of the National Institute on Pharmaceutical Technology and Education (NIPTE). He also served on the commission on credentialing for the ASHP. He was selected as "Pharmacist of the Year" by the Michigan Pharmacists Association and has been honored by his alma mater, Purdue University, with a Distinguished Alumnus Award and the Glen A. Sperandio Award for achievement in pharmacy. He is currently a member of the education advisory committee for the National Association of Chain Drug Stores. Vanderveen is a member of the American Association of Pharmaceutical Scientists, the American Society of Consultant Pharmacists, the American College of Clinical Pharmacy, the Academy of Managed Care Pharmacists, the College of Psychiatric and Neurologic Pharmacists and the National Community Pharmacists Association. Vanderveen has published referred articles and book chapters on pharmacokinetics, innovative educational strategies and leadership in nationally recognized journals and has published op-eds in the Wall Street Journal and Politico on issues of improving healthcare delivery. Vanderveen received a Bachelor of Science degree in pharmacy and a master of science degree in clinical pharmacy from Purdue University. He completed an ASHP-accredited residency at Bronson Medical Center in Kalamazoo, Mich. Vanderveen received his Ph.D. in university administration from Michigan State University.

Research Interest

Healthcare